Scope for using plant viruses to present epitopes from animal pathogens

Area of Science:

• Biotechnology
• Immunology
• Virology

Background:

• Epitope presentation is crucial for vaccination, achievable via pathogen forms or isolated antigenic sequences.
• Free peptides can adopt non-native conformations, limiting immunogenicity.
• Carrier proteins enhance peptide immunogenicity by restricting mobility and increasing local concentration.

Purpose of the Study:

• To explore plant viruses as novel, safer, and cost-effective vectors for epitope presentation in vaccine development.
• To evaluate the potential of plant virus-based systems as alternatives to traditional bacterial or animal virus vectors.

Main Methods:

• Utilized both helical (e.g., tobacco mosaic virus) and icosahedral (e.g., cowpea mosaic virus) plant virus particles as expression platforms.
• Engineered plant virus vectors to express various animal B-cell epitopes.
• Cultivated engineered plants for high-yield production of virus-based vectors.

Main Results:

• Plant virus-based vectors can be produced cheaply and in high yields (exceeding 1 mg/g plant tissue).
• Demonstrated the expression of multiple animal B-cell epitopes on different plant virus scaffolds.
• Investigated the immunogenic properties of these expressed epitopes to varying degrees.

Conclusions:

• Plant viruses represent a promising and safer alternative to conventional vaccine vectors, avoiding issues like reversion and contamination.
• The cost-effectiveness and high yield of plant virus production make them attractive for large-scale vaccine development.
• Further exploration of plant virus-based epitope presentation is warranted to fully harness their immunogenic potential.